REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Warsaw Genomics S.A. (Poland)

Main Activities: Medical and Diagnostic Laboratories
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals | Specialty (except Psychiatric and Substance Abuse) Hospitals | Diet and Weight Reducing Centers
Full name: Warsaw Genomics S.A. Profile Updated: February 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Warsaw Genomics is a Warsaw, Poland-based firm founded in 2015. Warsaw Genomics is primarily involved in the education industry. Warsaw Genomics employs 11-50 people.

Headquarters
Ul. Zwirki I Wigury 101
Warsaw; Mazowieckie; Postal Code: 02-089

Contact Details: Purchase the Warsaw Genomics S.A. report to view the information.

Website: http://www.warsawgenomics.pl

Basic Information
Total Employees:
Purchase the Warsaw Genomics S.A. report to view the information.
Registered Capital:
Purchase the Warsaw Genomics S.A. report to view the information.
Financial Auditors:
Purchase the Warsaw Genomics S.A. report to view the information.
Incorporation Date:
August 10, 2022
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Warsaw Genomics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
4.66%▲
Total operating revenue
12.68%▲
Operating Profit/Loss (EBIT)
293.17%▲
EBITDA
186.38%▲
Net Profit/Loss for the Period
280.01%▲
Total Assets
74.21%▲
Total Equity
81.16%▲
Operating Profit Margin (ROS)
22.26%▲
Net Profit Margin
21.98%▲
Return on Equity (ROE)
22.97%▲
Quick Ratio
-1.42%▼
Cash Ratio
-2.87%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo